Summary
- Current Price
- As of today, BNTX price is $89.27, down -0.04% on
- Current Price All-Time High
- BNTX price is currently -80.76% below its historical high of $464.00 set on
- Market Cap
- BNTX current market cap is $22B, down -3.00% year-over-year
- PE Ratio
- BNTX PE ratio is unknown
- Revenue
- BNTX current annual revenue is $3.24B, up +8.84% year-over-year
- Next Earnings
- The next earnings release for BNTX is on
Profile
| Metric | Value |
|---|---|
| Full Name | BioNTech SE |
| Ticker | NASDAQ: BNTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | Germany |
| IPO | |
| Indexes | Not included |
| Website | biontech.de |
| Employees | 6,772 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $89.27 | |
| Price, 1D Change | -0.04% | |
| Market Cap | $22B | |
| TTM Dividend Yield | - | |
| PE Ratio | - | |
| Beta | 0.90 | |
| Revenue | $3B | |
| Revenue, 1Y Change | +8.84% | |
| EPS | -$5.30 | |
| EPS, 1Y Change | -77.21% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $2.13 | |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | -$5.30 | |
| EPS Estimate | N/A | -$3.99 |
| EPS Est. Change | N/A | +24.74% |
| Revenue | $3.24B | |
| Revenue Estimate | N/A | $2.20B |
| Revenue Est. Change | N/A | -32.04% |
| Current Price | $89.27 | |
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$3.28 | -$2.99 | +8.78% | |
| -$3.44 | -$5.30 | -54.20% | |
| -$3.99 | N/A | +24.74% | |
| -$3.15 | N/A | +40.66% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.65B | $2.98B | +12.39% | |
| $2.69B | $3.24B | +20.30% | |
| $2.20B | N/A | -32.04% | |
| $2.49B | N/A | -23.01% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -7.23% | |
| Price, 3Y | -32.41% | |
| Market Cap, 1Y | -3.00% | |
| Market Cap, 3Y | -29.63% | |
| Revenue, 1Y | +8.84% | |
| Revenue, 3Y | -82.20% | |
| EPS, 1Y | -77.21% | |
| EPS, 3Y | -113.36% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $89.27 | |
| SMA 200 | $104.33 | |
| SMA 200 vs Price | +16.86% | |
| SMA 50 | $105.31 | |
| SMA 50 vs Price | +17.97% | |
| Beta | 0.90 | |
| ATR | $4.39 | |
| 14-Day RSI | 36.74 | |
| 10-Day Volatility | 109.73% | |
| 1-Year Volatility | 50.65% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $2.13 | |
| Upcoming | N/A | N/A |
| Dividend Yield | - | |
| Total Dividend | - | |
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $3.24B | |
| EPS | -$5.30 | |
| Gross Profit | $2.51B | |
| Gross Margin | 77.64% | |
| Operating Profit | -$733.01M | |
| Operating Margin | -22.63% | |
| Net Income | -$1.28B | |
| Net Margin | -39.59% | |
| EBITDA | -$300.99M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.01 | |
| 7.54 | ||
| 7.49 | ||
| - | ||
| 4 | ||
| 6.08 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | - | |
| 6.75 | ||
| 0.99 | ||
| -18.66 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $22.58B | |
| $17.43B | ||
| $25.82B | ||
| $18.96B | ||
| $3.25B | ||
| $2.52B | ||
| Total Debt | $314.05M | |
| $61.31M | ||
| $628.21M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $4.52B | ||
| $3.25B | ||
| $724.32M | ||
| $0.00 | ||
| $432.02M | ||
| $0.00 | ||
| $96.27M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $514.63M | ||
| -$2.79B | ||
| -$59.70M | ||
| Capex | $845.30M | |
| -$330.67M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| TD Cowen | → | |
| Morgan Stanley | → | |
| Citigroup | → | |
| Canaccord Genuity | → | |
| BMO Capital | → | |
| Jefferies | → | |
| Goldman Sachs | → | |
| HC Wainwright & Co. | → | |
| UBS | → | |
| JP Morgan | → |
Analyst sentiment
Institutional ownership
Screeners with BNTX
FAQ
What is the ticker symbol for BioNTech SE?
The ticker symbol for BioNTech SE is NASDAQ:BNTX
Does BioNTech SE pay dividends?
No, BioNTech SE does not pay dividends
What sector is BioNTech SE in?
BioNTech SE is in the Healthcare sector
What industry is BioNTech SE in?
BioNTech SE is in the Biotechnology industry
What country is BioNTech SE based in?
BioNTech SE is headquartered in Germany
When did BioNTech SE go public?
BioNTech SE initial public offering (IPO) was on October 10, 2019
Is BioNTech SE in the S&P 500?
No, BioNTech SE is not included in the S&P 500 index
Is BioNTech SE in the NASDAQ 100?
No, BioNTech SE is not included in the NASDAQ 100 index
Is BioNTech SE in the Dow Jones?
No, BioNTech SE is not included in the Dow Jones index
When was BioNTech SE last earnings report?
BioNTech SE's most recent earnings report was on November 3, 2025
When does BioNTech SE report earnings?
The next expected earnings date for BioNTech SE is May 5, 2026
Data Sources & References
- BNTX Official Website www.biontech.de
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1776985/000177698526000017/0001776985-26-000017-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1776985/000177698526000017/0001776985-26-000017-index.htm
- BNTX Profile on Yahoo Finance finance.yahoo.com/quote/BNTX
- BNTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bntx